RecruitingNot ApplicableNCT04937998

PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT

THE USE OF FRESH PRP VS HA IN THE TREATMENT OF OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT Randomized Controlled Clinical Trial


Sponsor

Istituto Ortopedico Rizzoli

Enrollment

166 participants

Start Date

Oct 26, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to compare the 12-month clinical outcomes of patients with patellofemoral osteoarthritis undergoing infiltrative treatment with fresh PRP and HA


Eligibility

Min Age: 30 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Autologous PRP injection and a procedure called HA injection for people with patellofemoral osteoarthritis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 30 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAutologous PRP injection

Patients will be treated with a single injection of Autologous PRP (5 ml) in the knee joint affected by patellofemoral osteoarthritis

PROCEDUREHA injection

Patients will be treated with a single injections of Hyaluronic Acid (5 ml) in the knee joint affected by patellofemoral osteoarthritis


Locations(1)

Istituto Ortopedico Rizzoli

Bologna, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04937998


Related Trials